Abvc Biopharma (ABVC) EBIT Margin (2009 - 2026)
Abvc Biopharma (ABVC) reported EBIT Margin of -1776.98% for Q2 2026.
Powered by 
Analysis
Abvc Biopharma (ABVC) EBIT Margin (2009 - 2026) Analysis & Trends
For FY2025, Abvc Biopharma posted EBIT Margin of -22503.10%, down 21579.76 percentage points from FY2024.
- EBIT Margin has a five-year change of -20742.23 percentage points (FY2020 to FY2025).
- By year, EBIT Margin came in at -923.34% in FY2024 (+3515.90 pp), -4439.24% in FY2023 (-2880.70 pp), -1558.54% in FY2022 (+1731.53 pp) and -3290.07% in FY2021 (-1529.20 pp).
- The Q2 2026 figure ranks as the highest quarterly EBIT Margin since Q3 2024.
- The high point for year-over-year EBIT Margin in five years was Q2 2024 (a gain of 35177.40 percentage points); the low point was Q1 2024 (a drop of 234053.79 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 32.98% |
| 10 | Abvc Biopharma | 24.28 Mn | 21.86 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,776.98% |
| Dec 31, 2024 | -35,837.44% |
| Sep 30, 2024 | -77.66% |
| Jun 30, 2024 | -734.24% |
| Mar 31, 2024 | -235,539.83% |
| Dec 31, 2023 | -23,641.34% |
| Sep 30, 2023 | -13,566.31% |
| Jun 30, 2023 | -35,911.64% |
| Mar 31, 2023 | -1,486.05% |
| Dec 31, 2022 | -531.92% |
| Sep 30, 2022 | -8,790.94% |
| Jun 30, 2022 | -654.24% |
| Mar 31, 2022 | -24,235.08% |
| Sep 30, 2021 | -1,990.48% |
| Jun 30, 2021 | -6,474.08% |
| Mar 31, 2021 | -476.06% |
| Dec 31, 2020 | -7,799.30% |
| Sep 30, 2020 | -1,116.17% |
| Jun 30, 2020 | -527.13% |
| Mar 31, 2020 | -1,486.78% |
API Access
Abvc Biopharma EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();